trending Market Intelligence /marketintelligence/en/news-insights/trending/rkleqwtygfy8hpti56dlrw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Court sides with Pacific Biosciences in patent eligibility ruling

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Court sides with Pacific Biosciences in patent eligibility ruling

A U.S. court denied Oxford Nanopore Technologies Ltd's motion to dismiss a lawsuit filed by Pacific Biosciences of California Inc. for alleged patent infringement of its genome sequencing technology.

Judge Leonard Stark of the U.S. District Court for the District of Delaware denied the U.K.-based Oxford Nanopore's motion, which alleged that Pacific Biosciences' patent claims contain ineligible subject matter.

In November 2017, the U.S. District Court for the District of Delaware denied Oxford Nanopore's motion to dismiss another companion patent infringement case brought by Pacific Biosciences.

In a separate litigation in February, the U.S. International Trade Commission ruled that Oxford Nanopore did not infringe on Menlo Park, Calif.-based Pacific Biosciences' patents for certain molecule analysis devices.